Bavarian Nordic (OTCMKTS:BVNRY) Shares Pass Below Fifty Day Moving Average – Here’s Why

Bavarian Nordic (OTCMKTS:BVNRY)’s share price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $9.54 and traded as low as $9.07. Bavarian Nordic shares last traded at $9.33, with a volume of 4,138 shares.

Bavarian Nordic Price Performance

The company’s 50-day simple moving average is $9.54 and its 200-day simple moving average is $9.86. The company has a market cap of $2.22 billion, a price-to-earnings ratio of 12.28 and a beta of 1.20.

Bavarian Nordic (OTCMKTS:BVNRY) last posted its quarterly earnings data on Wednesday, May 13th. The company reported $0.01 earnings per share (EPS) for the quarter. Bavarian Nordic had a net margin of 19.74% and a return on equity of 9.32%. The company had revenue of $165.70 million for the quarter.

About Bavarian Nordic

Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.

The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.